Search Results - "Pohl, Gerhardt"

One‐Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort Study by Fowler, Nicole R., Campbell, Noll L., Pohl, Gerhardt M., Munsie, Leanne M., Kirson, Noam Y, Desai, Urvi, Trieschman, Erich J., Meiselbach, Mark K., Andrews, J. Scott, Boustani, Malaz A.

“…Objectives To examine the effect of the Medicare Annual Wellness Visit (AWV) on the detection of cognitive impairment and on follow‐up cognitive care for older…”
Get full text

Survival patterns in United States (US) medicare enrollees with non-CML myeloproliferative neoplasms (MPN) by Price, Gregory L, Davis, Keith L, Karve, Sudeep, Pohl, Gerhardt, Walgren, Richard A

“…Non-CML myeloproliferative neoplasms (MPN) include essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Reported median overall…”
Get full text

Analysis of the psychological impact of cancer‐related symptoms on patients with non‐small cell lung cancer by Walker, Mark S., Pohl, Gerhardt M., Houts, Arthur C., Peltz, Gerson, Miller, Paul J. E., Schwartzberg, Lee S., Stepanski, Edward J., Marciniak, Martin

“…Background Patients with non‐small cell lung cancer (NSCLC) experience adverse physical symptoms because of cancer, cancer treatment, and comorbidities. The…”
Get full text

Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers by Karve, Sudeep J, Price, Gregory L, Davis, Keith L, Pohl, Gerhardt M, Smyth, Emily Nash, Bowman, Lee

“…Limited data exist regarding real-world treatment patterns, resource utilization, and costs of extensive-stage small cell lung cancer (esSCLC) among elderly…”
Get full text

A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD) by Pohl, Gerhardt M, Van Brunt, David L, Ye, Wenyu, Stoops, William W, Johnston, Joseph A

“…Combination therapy in managing psychiatric disorders is not uncommon. While combination therapy has been documented for depression and schizophrenia, little…”
Get full text

Treatment patterns and cost-effectiveness of first line treatment of advanced non-squamous non-small cell lung cancer in Medicare patients by Gilden, Daniel M, Kubisiak, Joanna M, Pohl, Gerhardt M, Ball, Daniel E, Gilden, David E, John, William J, Wetmore, Stewart, Winfree, Katherine B

“…To assess the cost-effectiveness of first-line pemetrexed/platinum and other commonly administered regimens in a representative US elderly population with…”
Get more information

Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates by Foster, Shonda A, Foley, Kathleen A, Meadows, Eric S, Johnston, Joseph A, Wang, Sara, Pohl, Gerhardt M, Long, Stacey R

“…Both raloxifene and bisphosphonates are indicated for the prevention and treatment of postmenopausal osteoporosis, however these medications have different…”
Get full text

Illness-Associated Productivity Costs Among Women With Employer-Sponsored Insurance and Newly Diagnosed Breast Cancer by Meadows, Eric S., Johnston, Stephen S., Cao, Zhun, Foley, Kathleen A., Pohl, Gerhardt M., Johnston, Joseph A., Ramsey, Scott D.

“…Objective: Determine lost work time and job attrition for incident breast cancer (BC). Methods: The cases were employed women, aged 18 to 64, with BC…”
Get full text

Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD by Martin, R J, Bartelson, B L, Smith, P, Hudgel, D W, Lewis, D, Pohl, G, Koker, P, Souhrada, J F

“…Patients with COPD are at risk of experiencing a deterioration in arterial oxygen saturation (SaO2) during sleep, which is generally most pronounced during…”
Get more information

Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study by Gold, Deborah T., Weinstein, David L., Pohl, Gerhardt M., Krohn, Kelly D., Chen, Yi, Meadows, Eric S.

“…Purpose. Determine patient-reported reasons for discontinuation with teriparatide. Methods. Patients taking teriparatide in a multicenter, prospective, and…”
Get full text

Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung Cancer by Muehlenbein, Catherine E., Hoverman, J. Russell, Gruschkus, Stephen K., Forsyth, Michael, Chen, Clara, Lopez, William, Lawson, Anthony, Hartnett, Heather J., Pohl, Gerhardt

“…Background. Traditional methods for identifying comorbidity data in EMRs have relied primarily on costly and time-consuming manual chart review. The purpose of…”
Get full text

Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer by Pike, Crystal T., Birnbaum, Howard G., Muehlenbein, Catherine E., Pohl, Gerhardt M., Natale, Ronald B.

“…Objective. Chemotherapy-associated peripheral neuropathy (CAPN) is a painful side-effect of chemotherapy. This study assesses healthcare and workloss costs of…”
Get full text

Synergistic Effect of Multimorbidity of Obesity-Related Comorbidities on Healthcare Costs by Pohl, Gerhardt, Ezendu, Kyrian, Lee, Clare, Wang, Hui, Li, Xiaohong, Dunn, Julia

“…Background: Increasing age and weight are associated with higher prevalence of multimorbidity (MM) with 50% risk for MM being reached >5 years earlier for each…”
Get full text

Predictors of Selecting Atomoxetine Therapy for Children with Attention-Deficit-Hyperactivity Disorder by Van Brunt, David L., Johnston, Joseph A., Ye, Wenyu, Pohl, Gerhardt M., Sun, Pei J., Sterling, Kimberly L., Davis, Martha E.

“…Study Objective. To investigate predictors of beginning treatment with atomoxetine, a new attention‐deficit—hyperactivity disorder (ADHD) drug, shortly after…”
Get full text

Budget impact of lasmiditan for the acute treatment of migraine in the United States by Milev, Sandra, Pohl, Gerhardt, Sun, Ariel, Mason, Oksana, Njuguna, Nancy, Loo, Li Shen

“…Three novel acute treatments for migraine-lasmiditan, ubrogepant, and rimegepant-were approved by the FDA in 2019 and 2020 for adults with migraine with and…”
Get full text

Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant by Doty, Erin G., Krege, John H., Pohl, Gerhardt, Case, Michael, Dowsett, Sherie A., Tepper, Stewart J.

Get full text

SAT659 Prevalence Of Multimorbidity Across Age Groups Among Us Adults With Overweight Or Obesity by Ezendu, Kyrian, Pohl, Gerhardt, Eun Lee, Clare Jung, Wang, Hui, Li, Xiaohong, Dunn, Julia P

“…Abstract Disclosure: K. Ezendu: Employee; Self; Eli Lilly & Company. G. Pohl: Employee; Self; Eli Lilly & Company. Stock Owner; Self; Eli Lilly & Company. C.J…”
Get full text

Perspectives of quality care in cancer treatment: a review of the literature by Hess, Lisa M, Pohl, Gerhardt

“…Approximately 1.7 million Americans are diagnosed with cancer annually. There is an increasing demand for high-quality cancer care; however, what constitutes…”
Get full text

Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancer: The psychological impact of cancer-related symptoms in NSCLC by Walker, Mark S., Pohl, Gerhardt M., Houts, Arthur C., Peltz, Gerson, Miller, Paul J. E., Schwartzberg, Lee S., Stepanski, Edward J., Marciniak, Martin

Get full text

Survival Patterns in United States by Price, Gregory L, Davis, Keith L, Karve, Sudeep, Pohl, Gerhardt, Walgren, Richard A

“…Purpose Non-CML myeloproliferative neoplasms (MPN) include essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Reported median…”
Get full text